The shot that’s been embraced by adult diabetics proved similarly beneficial for younger patients, reducing their blood sugar levels by an average of about 2%, according to results released at the European Association for the Study of Diabetes conference in Vienna. They also lost more than 10% of their body weight after a year of treatment.
Lilly said it’s submitted the results of the study involving about 100 ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
